首页 › 基金 › Defilade Capital Management, L.P. › PTCT
Defilade Capital Management, L.P. 对 PTCT 的持仓历史
PTC THERAPEUTICS INC · 医疗保健
Defilade Capital Management, L.P. 在 Q2 2026 的 13F 申报中披露持有 PTCT(PTC THERAPEUTICS INC)433,699 股,市值约 US$35.4M,约占其申报组合的 4.74%,在其申报持仓中市值排名第 5 位。 Defilade Capital Management, L.P. 最近 2 个申报季度中有 2 个季度披露了 PTCT 持仓,最早可追溯至 Q1 2026。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
Defilade Capital Management, L.P. 对 PTCT 的持仓演变
Defilade Capital Management, L.P. 于 Q1 2026 首次披露 PTCT 持仓:376,165 股(约 US$25.6M)。 该持仓在 Q2 2026 达到峰值 433,699 股,市值约 US$35.4M。 在 2 次申报中,Defilade Capital Management, L.P. 1 次增持、0 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 433,699 股、市值约 US$35.4M,环比增持 57,534 股。。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q1 2026 | 376.17K | $25.63M | 新进 |
| Q2 2026 | 433.70K | $35.38M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 PTCT 与 13F 数据
PTCT(PTC THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 54 只申报持有 PTCT,申报仓位最大的包括:RTW INVESTMENTS, LP (US$631.9M), TORONTO DOMINION BANK (US$176.7M), WESTFIELD CAPITAL MANAGEMENT CO LP (US$159.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 PTCT 的基金
- RTW INVESTMENTS, LP 7.75M 股 · $631.88M · Q2 2026
- TORONTO DOMINION BANK 2.17M 股 · $176.67M · Q2 2026
- WESTFIELD CAPITAL MANAGEMENT CO LP 1.96M 股 · $159.56M · Q2 2026
- Hood River Capital Management LLC 1.74M 股 · $141.82M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 1.50M 股 · $122.36M · Q2 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 1.44M 股 · $117.47M · Q2 2026
- Jefferies Financial Group Inc. 1.36M 股 · $110.69M · Q2 2026
- Blue Sparrow, LLC /DE 1.05M 股 · $85.71M · Q2 2026
- Palo Alto Investors LP 918.85K 股 · $74.95M · Q2 2026
- ARMISTICE CAPITAL, LLC 660.00K 股 · $53.84M · Q2 2026
- Parkman Healthcare Partners LLC 435.69K 股 · $35.54M · Q2 2026
更多关于 Defilade Capital Management, L.P.
常见问题
How long has Defilade Capital Management, L.P. held PTCT?
Defilade Capital Management, L.P. has disclosed PTCT holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is Defilade Capital Management, L.P.'s current position in PTCT?
As of Q2 2026, Defilade Capital Management, L.P. holds 433.70K shares of PTCT (PTC THERAPEUTICS INC), valued at $35.38M, representing 4.74% of its reported portfolio and ranking #5.
Has Defilade Capital Management, L.P. been buying or selling PTCT?
In the latest 13F filing (Q2 2026), Defilade Capital Management, L.P. increased its position in PTCT. The position peaked in Q2 2026 at 433.70K shares.
Which other funds hold PTCT?
Other major institutional holders of PTCT include RTW INVESTMENTS, LP, TORONTO DOMINION BANK, WESTFIELD CAPITAL MANAGEMENT CO LP, among 54 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.